Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

F-3

NeuroSense Therapeutics Ltd.

Table 1: Newly Registered and Carry Forward Securities

Line Item Type		Security Type		Security Class Title		Notes		Fee Calculation Rule		Amount Registered		Proposed Maximum Offering Price Per Unit			Maximum Aggregate Offering Price			Fee Rate		Amount of Registration Fee
Newly Registered Securities
Fees to be Paid		Equity		Ordinary shares, no par value per share		(1)		Other		333,334		$	1.15		$	383,334.10		0.0001381		$	52.94
Total Offering Amounts:															$	383,334.10					52.94
Total Fees Previously Paid:
Total Fee Offsets:																					0.00
Net Fee Due:																				$	52.94

__________________________________________
Offering Note(s)

(1) Pursuant to Rule 416(a) under the U.S. Securities Act of 1933, as amended (the “Securities Act”), the securities being registered hereunder also include such indeterminable number of additional securities as may from time to time be issued after the date hereof as a result of share splits, share dividends, recapitalizations or similar transactions.

Represents 333,334 ordinary shares, no par value per share (the “Ordinary Shares”), of NeuroSense Therapeutics Ltd. (the “Company”), issued in a private placement to the selling shareholder identified in the registration of which this exhibit forms a part. The Company will not receive any proceeds from the sale of its Ordinary Shares by the selling shareholder.

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) promulgated under the Securities Act, as amended, based on the average of the equivalent high ($1.18) and low ($1.12) sales prices of the Ordinary Shares on the Nasdaq Capital Market on October 27, 2025.